Advanced Medical Solutions (AMS) Stock Statistics & Valuation Metrics

Advanced Medical Solutions has a market cap or net worth of GBX 616.74M. The enterprise value is GBX 680.02M.

Market Cap

GBX 616.74M

Enterprise Value

GBX 680.02M

Advanced Medical Solutions has 221,129,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

221,129,300

Owned by Insiders

―

Owned by Institutions

4.52%

Advanced Medical Solutions’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.47%.

Return on Equity (ROE)

0.04

Return on Assets (ROA)

0.03

Return on Invested Capital (ROIC)

3.47%

Return on Capital Employed (ROCE)

0.06

Revenue Per Employee

127.19K

Profits Per Employee

5,530

Employee Count

1,800

Asset Turnover

0.58

Inventory Turnover

1.72

The current PE Ratio of Advanced Medical Solutions is 166.47. Advanced Medical Solutions’s PEG ratio is -2.78.

PE Ratio

166.47

PS Ratio

2.64

PB Ratio

2.41

Price to FCF

77.58

Price to Operating Cash Flow

30.10

PEG Ratio

-2.78

In the last 12 months, Advanced Medical Solutions had revenue of 228.94M and earned 9.95M in profits. Earnings per share was 0.05.

Revenue

228.94M

Gross Profit

108.78M

Operating Income

21.99M

Pretax Income

17.78M

Net Income

9.95M

EBITDA

43.39M

Earnings Per Share (EPS)

0.05

In the last 12 months, operating cash flow was 20.38M and capital expenditures -12.43M, giving a free cash flow of 7.95M billion.

Operating Cash Flow

20.38M

Free Cash Flow

7.95M

Free Cash Flow per Share

0.04

Advanced Medical Solutions pays an annual dividend of GBX 2.01, resulting in a dividend yield of 1.66%

Dividend Per Share

GBX 2.01

Dividend Yield

1.66%

Payout Ratio

38.65%

Free Cash Flow Yield

1.29%

Earnings Yield

0.60%

Beta

1.01

52-Week Price Change

32.86%

50-Day Moving Average

281.96

200-Day Moving Average

248.11

Relative Strength Index (RSI)

57.10

Average Volume (3m)

1.61M

Advanced Medical Solutions upcoming earnings date is Mar 17, 2027, TBA (Not Confirmed).

Last Earnings Date

Sep 16, 2026

Next Earnings Date

Mar 17, 2027

Ex-Dividend Date

May 28, 2026

Advanced Medical Solutions as a current ratio of 2.79, with Debt / Equity ratio of 31.50%

Current Ratio

2.79

Quick Ratio

1.39

Debt to Market Cap

0.15

Net Debt to EBITDA

1.46

Interest Coverage Ratio

4.32

In the past 12 months, Advanced Medical Solutions has paid 7.69M in taxes.

Income Tax

7.69M

Effective Tax Rate

0.43

Advanced Medical Solutions EV to EBITDA ratio is 14.26, with an EV/FCF ratio of 86.61.

EV to Sales

2.95

EV to EBITDA

14.26

EV to Free Cash Flow

86.61

EV to Operating Cash Flow

33.78

Advanced Medical Solutions has GBX 13.56M in cash and marketable securities with GBX 85.37M in debt, giving a net cash position of -GBX 71.81M billion.

Cash & Marketable Securities

GBX 13.56M

Total Debt

GBX 85.37M

Net Cash

-GBX 71.81M

Net Cash Per Share

-GBX 0.32

Tangible Book Value Per Share

GBX 0.27

Gross margin is 47.94%, with operating margin of 11.29%, and net profit margin of 1.58%.

Gross Margin

47.94%

Operating Margin

11.29%

Pretax Margin

4.13%

Net Profit Margin

1.58%

EBITDA Margin

20.67%

EBIT Margin

11.29%

The average price target for Advanced Medical Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

6.05%

EPS Growth Forecast

-60.00%

Smart Score

5

AI Score

57